| |
|
Form Serial Number: |
DA20220415E00027
|
| 1.
Date of relevant event: |
31/03/2022
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02179 |
| 4.
Name of listed corporation: |
Jiangsu Recbio Technology Co., Ltd. - B - H Shares |
| 5.
Class of shares: |
Domestic Shares |
| 6.
Number of issued shares in class: |
377,322,880 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
LIU |
| (Other names) |
YONG |
|
|
|
| 10.
Name of director (Chinese): |
刘勇 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1701 | Miscellaneous
On listing of the corporation or a class of shares of the listed corporation |
|
|
|
|
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| | | |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 96,941,440 | 25.69 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Taizhou Yuangong Technology Partnership (Limited Partnership) (泰州元工科技合夥企業(有限合夥)) | Room A215, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陆家路西側、濱河路北側疫苗工程中心A215室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
| Taizhou Baibei Biology Technology Partnership (Limited Partnership) (泰州百倍生物科技合夥企業(有限合夥)) | Room A213, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陸家路西側、濱河路北側疫苗工程中心A213室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
| Taizhou Guquan Biology Technology Partnership (Limited Partnership) (泰州古泉生物科技合夥企業(有限合夥)) | Room A214, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陸家路西側、濱河路北側疫苗工程中心A214室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
| Lianyungang Ruibaitai Medical Technology Partnership (Limited Partnership) (連雲港瑞百泰醫藥科技合夥企業(有限合夥)) | 088 Longjizhen Street, Guanyun Country, Lianyuguang City, the People's Republic of China (中國連雲港市灌雲縣龍苴鎮中大街088號) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Dr. Liu, as the sole general partner of the employee ownership platforms set out in Box 30, is able to exercise the voting rights of the Domestic Shares held by each of Taizhou Yuangong Technology Partnership (Limited Partnership), Taizhou Baibei Biology Technology Partnership (Limited Partnership), Taizhou Guquan Biology Technology Partnership (Limited Partnership) and Lianyungang Ruibaitai Medical Technology Partnership (Limited Partnership).
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
15/04/2022
(dd/mm/yyyy)
|
| |